These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical psychopharmacology and inpatient psychiatry: the revolution, its achievements and its dangers. Alarcon RD; Walter-Ryan WG Psychiatr Med; 1986; 4(4):387-406. PubMed ID: 2893433 [No Abstract] [Full Text] [Related]
24. Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics. Freudenreich O; McEvoy JP J Clin Psychiatry; 1995 Apr; 56(4):173. PubMed ID: 7713860 [No Abstract] [Full Text] [Related]
25. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
26. [Cerebellar degeneration following acute lithium intoxication]. Roy M; Stip E; Black D; Lew V; Langlois R Rev Neurol (Paris); 1998 Jul; 154(6-7):546-8. PubMed ID: 9773090 [TBL] [Abstract][Full Text] [Related]
27. [Parkinsonism during lithium use]. Walrave TR; Bulens C Tijdschr Psychiatr; 2009; 51(2):123-7. PubMed ID: 19194854 [TBL] [Abstract][Full Text] [Related]
28. [Neuroleptics and tranquilizers: indications and dangers]. Möller HJ Med Klin (Munich); 1986 May; 81(11):385-8. PubMed ID: 2878353 [No Abstract] [Full Text] [Related]
29. Lithium and extrapyramidal side effects of neuroleptics. Weiden P Am J Psychiatry; 1987 Feb; 144(2):264-5. PubMed ID: 2880518 [No Abstract] [Full Text] [Related]
31. Decreased extrapyramidal side effects and polypsichopharmacy in family practice outpatients. Holt RJ Bol Asoc Med P R; 1983 Aug; 75(8):351-2. PubMed ID: 6139115 [No Abstract] [Full Text] [Related]
32. Lithium-neuroleptics combination and irreversible brain damage. Baptista T Acta Psychiatr Scand; 1986 Jan; 73(1):111. PubMed ID: 2870609 [No Abstract] [Full Text] [Related]
33. [Tardive dyskinesia: an increased risk of neuroleptics in elderly women]. Jessurun AY; Stek ML Tijdschr Gerontol Geriatr; 1995 Oct; 26(5):197-9. PubMed ID: 8750979 [TBL] [Abstract][Full Text] [Related]
34. [Complications of drug withdrawal from antiparkinson agents and neuroleptics]. Mizon JP; Rosa A Therapie; 1984; 39(4):421-5. PubMed ID: 6148792 [No Abstract] [Full Text] [Related]
35. [Withdrawal symptoms of neuroleptics?]. Mager T Med Monatsschr Pharm; 1994 Aug; 17(8):252. PubMed ID: 7935155 [No Abstract] [Full Text] [Related]
36. [Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder]. Böker H; Brandenberger M; Schopper C Psychiatr Prax; 2007 Jan; 34(1):38-41. PubMed ID: 17106843 [TBL] [Abstract][Full Text] [Related]
37. [Severe tardive dyskinesia during treatment with risperidone and fluoxetine]. Dubbelman YD; Thung FH; Heeringa M Ned Tijdschr Geneeskd; 1998 Jun; 142(26):1508-11. PubMed ID: 9752071 [TBL] [Abstract][Full Text] [Related]
38. [Complications observed during use of lithium salt-neuroleptic combinations; comparative study of clinical evolution, EEG and pharmacokinetics]. Granier F; Girard M; Loustalan JM; Thomas J; Escande M Ann Med Psychol (Paris); 1983; 141(8):891-908. PubMed ID: 6141759 [No Abstract] [Full Text] [Related]
39. [News of the pharmacology of neuroleptics in 1982]. Valchár M Cesk Psychiatr; 1983 Oct; 79(5):306-14. PubMed ID: 6139174 [No Abstract] [Full Text] [Related]